Literature DB >> 23850698

Development and validation of three Capripoxvirus real-time PCRs for parallel testing.

A Haegeman1, K Zro, F Vandenbussche, L Demeestere, W Van Campe, M M Ennaji, K De Clercq.   

Abstract

Capripoxviruses have the potential to cause outbreaks with a severe socio-economic impact. The latter, combined with an altered virus dissemination pattern, warrants its status as an important emerging disease. Disease control or eradication programmes can only be applied successfully if the necessary diagnostic tools are available allowing clear and unequivocal identification of the pathogen. Real-time PCR combines high sensitivity/specificity with a reduced analysis time and is thus a proven useful tool for identification of many pathogens, including Capripoxviruses. In order for a real-time PCR to be used in a diagnostic capacity, the different analytical and diagnostic parameters need to be evaluated to assure data quality. The implementation of parallel testing using multiple real-time PCRs with similar characteristics can improve further Capripoxvirus diagnosis. It was therefore the purpose of this study to develop a triplet real-time PCR panel with similar high sensitivity/specificity and provide sufficient validation data regarding the performance characteristics that the panel can be used in parallel, depending on the purpose and local situation.
Copyright © 2013 Elsevier B.V. All rights reserved.

Keywords:  Capripoxvirus; Diagnostics; Parallel testing; Real-time PCR; Validation

Mesh:

Year:  2013        PMID: 23850698     DOI: 10.1016/j.jviromet.2013.07.010

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  11 in total

1.  Assessment of the control measures of the category A diseases of Animal Health Law: sheep and goat pox.

Authors:  Søren Saxmose Nielsen; Julio Alvarez; Dominique Joseph Bicout; Paolo Calistri; Elisabetta Canali; Julian Ashley Drewe; Bruno Garin-Bastuji; José Luis Gonzales Rojas; Christian Gortázar; Mette Herskin; Virginie Michel; Miguel Ángel Miranda Chueca; Barbara Padalino; Paolo Pasquali; Liisa Helena Sihvonen; Hans Spoolder; Karl Ståhl; Antonio Velarde; Arvo Viltrop; Christoph Winckler; Kris De Clercq; Simon Gubbins; Inma Aznar; Alessandro Broglia
Journal:  EFSA J       Date:  2021-12-27

2.  An Immunoperoxidase Monolayer Assay (IPMA) for the detection of lumpy skin disease antibodies.

Authors:  Andy Haegeman; Ilse De Leeuw; Laurent Mostin; Willem Van Campe; Laetitia Aerts; Maria Vastag; Kris De Clercq
Journal:  J Virol Methods       Date:  2019-12-16       Impact factor: 2.014

3.  Assessment of the control measures for category A diseases of Animal Health Law: Lumpy Skin Disease.

Authors:  Søren Saxmose Nielsen; Julio Alvarez; Dominique Joseph Bicout; Paolo Calistri; Elisabetta Canali; Julian Ashley Drewe; Bruno Garin-Bastuji; José Luis Gonzales Rojas; Christian Gortázar Schmidt; Mette Herskin; Virginie Michel; Miguel Ángel Miranda Chueca; Barbara Padalino; Paolo Pasquali; Liisa Helena Sihvonen; Hans Spoolder; Karl Ståhl; Antonio Velarde; Arvo Viltrop; Christoph Winckler; Kris De Clercq; Simon Gubbins; Eyal Klement; Jan Arend Stegeman; Sotiria-Eleni Antoniou; Inma Aznar; Alessandro Broglia; Yves Van der Stede; Gabriele Zancanaro; Helen Clare Roberts
Journal:  EFSA J       Date:  2022-01-24

4.  A Tale of Tails: Dissecting the Enhancing Effect of Tailed Primers in Real-Time PCR.

Authors:  Frank Vandenbussche; Elisabeth Mathijs; David Lefebvre; Kris De Clercq; Steven Van Borm
Journal:  PLoS One       Date:  2016-10-10       Impact factor: 3.240

5.  Recombinase polymerase amplification assay for rapid detection of lumpy skin disease virus.

Authors:  Mohamed A Shalaby; Ayman El-Deeb; Mohamed El-Tholoth; Donata Hoffmann; Claus-Peter Czerny; Frank T Hufert; Manfred Weidmann; Ahmed Abd El Wahed
Journal:  BMC Vet Res       Date:  2016-11-02       Impact factor: 2.741

6.  Molecular characterization of lumpy skin disease virus (LSDV) emerged in Bangladesh reveals unique genetic features compared to contemporary field strains.

Authors:  Shukes Chandra Badhy; Mohammad Golam Azam Chowdhury; Tirumala Bharani Kumar Settypalli; Giovanni Cattoli; Charles Euloge Lamien; Mohammad Aflak Uddin Fakir; Shamima Akter; Mozaffar Goni Osmani; Faisol Talukdar; Noorjahan Begum; Izhar Ahmed Khan; Md Bazlur Rashid; Mohammad Sadekuzzaman
Journal:  BMC Vet Res       Date:  2021-01-29       Impact factor: 2.741

7.  A robust, cost-effective and widely applicable whole-genome sequencing protocol for capripoxviruses.

Authors:  Elisabeth Mathijs; Andy Haegeman; Kris De Clercq; Steven Van Borm; Frank Vandenbussche
Journal:  J Virol Methods       Date:  2022-01-13       Impact factor: 2.014

8.  Comparative Evaluation of Lumpy Skin Disease Virus-Based Live Attenuated Vaccines.

Authors:  Andy Haegeman; Ilse De Leeuw; Laurent Mostin; Willem Van Campe; Laetitia Aerts; Estelle Venter; Eeva Tuppurainen; Claude Saegerman; Kris De Clercq
Journal:  Vaccines (Basel)       Date:  2021-05-08

9.  Experimental evidence of mechanical lumpy skin disease virus transmission by Stomoxys calcitrans biting flies and Haematopota spp. horseflies.

Authors:  C Sohier; A Haegeman; L Mostin; I De Leeuw; W Van Campe; A De Vleeschauwer; E S M Tuppurainen; T van den Berg; N De Regge; K De Clercq
Journal:  Sci Rep       Date:  2019-12-27       Impact factor: 4.379

10.  Validation of TaqMan-Based Assays for Specific Detection and Differentiation of Wild-Type and Neethling Vaccine Strains of LSDV.

Authors:  Dejan Vidanović; Bojana Tešović; Milanko Šekler; Zoran Debeljak; Nikola Vasković; Kazimir Matović; Andrey Koltsov; Kiril Krstevski; Tamaš Petrović; Ilse De Leeuw; Andy Haegeman
Journal:  Microorganisms       Date:  2021-06-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.